In addition, several genetic alterations, like loss of heterozygosity, PTEN, PIK3CA, KRAS, and TP53 mutations have been identified in both endometriosis and endometriosis-associated malignancy [125,126,127]. This evidence concerns the gene TP53 and endometriosis.